Provider review

MEDVi tirzepatide review

MEDVi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

Illustration of bottles and boxes lined up on a shelf

Updated 2026-09-18 · Public-source editorial · See dated evidence below


MEDVi offers compounded tirzepatide as both a weekly injection and a tablet, and publishes the price of only one of them.

Injections are listed at $399 a month, consistent between the first month and renewals, which is at least honest. Tablet pricing is quoted only after you have completed the intake questionnaire — meaning you hand over health information before you learn what it costs.

Recorded costs and what to confirm

Comparison stepTirzepatide at MEDVi
Earlier figuresDated cost record
TreatmentName the product, route, prescribed amount and supply period
First paymentItemize medicine, care, tests, supplies and delivery
RenewalGive the next charge, its date and the supply it covers
Change or exitExplain remaining charges and any refund before payment

Consistent month to month, but high.

At $399 a month, a year runs roughly $4,788. That is approximately double Coreage Rx month-to-month and triple its annual plan, for the same class of compounded product.

How MEDVi works

Compounded GLP-1 provider offering weekly injections and a tablet formulation, with tablet pricing quoted after intake rather than published.

The injection programme is conventional and competently run. Pricing does not jump after month one, which is more than several competitors manage. The tablet option is genuinely useful for needle-averse patients, assuming you are willing to complete intake to find out what it costs.

The earlier source record

  • Compounded tirzepatide injections listed at $399/month.
  • Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.

The underlying record is dated 2026-09-18. Its amounts, plan details and service descriptions are historical. Confirm the exact product, billing interval, included services and renewal terms before using a figure as a budget.

Where it is strong

  • Injection pricing is consistent between the first month and renewals.
  • Tablet option for people who will not inject.

Where it falls short

  • Tablet pricing is withheld until after you have handed over health information.
  • $399/month is roughly double the flat-rate leaders.

The thing most people miss

You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.

How it scored

The historical rubric gives MEDVi 2.8 out of 5. Display position 23 of 23 also reflects commercial placements; it is not a clinical quality rank. These scores have not been independently revalidated. See how we rate.

What we weighWeightScore
True monthly cost30%2.4 / 5
Price honesty20%2.5 / 5
Clinical support20%3.3 / 5
Pharmacy sourcing15%3.2 / 5
Cancelling15%3 / 5

Who it suits

Reasonable for someone who wants a tablet option and does not mind the intake-first pricing. Hard to justify for a straightforward weekly injection.

Our verdict

Consistent pricing on the injection, withheld pricing on the tablet, and a figure that is high either way. Ask for the tablet price in writing before you start.

How it compares on tirzepatide

The full reasoning behind this order is in our best tirzepatide providers guide.

Read next

  • Coreage Rx tirzepatide review

    Coreage Rx tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

  • Likeness Rx semaglutide review

    Likeness Rx semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

  • Trimi tirzepatide review

    Trimi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

  • The best tirzepatide providers in 2026

    23 historical provider records, with cost-component questions, clinical evidence limits and commercial placements explained.

  • Tirzepatide vs semaglutide

    One trial put them head to head. The result was not close — but the cheaper drug still wins for some people.

  • How to Compare GLP-1 Costs: Fees, Refills and Renewal

    Separate medication, care fees, supply duration, prepayment and renewal when comparing a GLP-1 quote.

Coreage Rx pays us a commission on sign-ups through our links. Commercial placements affect display order; the tables are not clinical recommendations. How we rate · Disclosure